This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Takahiro Matsusaka, PhD
Senior Scientist at Chiome Bioscience
Speaker

Profile

Takahiro Matsusaka is a senior scientist at Chiome Bioscience Inc. who has a proprietary antibody screening platform called the ADLib system. He received his PhD in molecular biology at Kyoto University and did a postdoc at the Gurdon Institute in Cambridge. He moved to Horizon Discovery, where he worked on diagnostic product development. He returned to Japan to join Chiome Bioscience Inc. in 2021, where he is focusing on developing new technologies and applications in the field of antibody discovery.

Agenda Sessions

  • Automated Bioinformatics Pipelines for Rapid In Silico Analysis – A Case Study of Versatile Antibody Assessment and In Vitro Selection

    15:30